Flarex Suspension/ Drops
Product Images NDC 82667-010

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Flarex (NDC 82667-010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Harrow Eye, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton.jpg (Carton)

This information is about Flarex, an ophthalmic suspension containing 0.1% fluorometholone acetate. The recommended dosage is one to two drops instilled into the conjunctival sac(s) four times daily. It can be increased to two drops every two hours for the first 24 to 48 hours. If there is no improvement after two weeks, consult a physician. The product should be stored upright between 2°C to 25°C (36°F to 77°F) and protected from freezing. After opening, Flarex can be used until the expiration date on the bottle. The preparation includes benzalkonium chloride as a preservative and other inactive ingredients.*

FDA Label Image

Flarex-01.jpg (Flarex 01)

FDA Label Image

Samplecarton.jpg (Samplecarton)

This is information about Flarex, an ophthalmic suspension containing fluorometholone acetate 0.1%. It provides details on storage instructions, recommended dosage, and inactive ingredients. The medication is intended for topical ophthalmic use, and caution is advised against discontinuing therapy prematurely. The text also mentions dosage adjustment in the initial phase and the need for consultation with a physician if there is no improvement after two weeks.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.